ResMed stock pre-market at EUR 199.20: plus 0.48 percent

ResMed stock is at EUR 199.20 pre-market, up 0.48 percent versus the prior Lang & Schwarz close. ResMed plans to report first-quarter fiscal 2027 results on October 29.

ResMed stock is at EUR 199.20 pre-market on October 6, 2026, at 8:28 a.m. CEST, according to Lang & Schwarz. That is a plus 0.48 percent change versus the Lang & Schwarz prior close of EUR 198.25 on October 5, 2026.

ResMed pre-market price

The Lang & Schwarz bid is EUR 197.60 and the ask is EUR 200.80. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of ResMed stock.

Fiscal 2027 first-quarter report scheduled

ResMed said in a GlobeNewswire release dated October 1, 2026, that it plans to publish financial and operational results for the first quarter of fiscal 2027 on October 29, 2026, after the New York Stock Exchange closes. Management is scheduled to host a webcast at 1:30 p.m. Pacific Time, or 4:30 p.m. Eastern Time, on the same day.